OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Infection Challenge with Serotype 3 Pneumococcus
Ryan Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 11, pp. 1379-1392
Open Access | Times Cited: 12

Showing 12 citing articles:

Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine Introduction
Akuzike Kalizang’oma, Todd D. Swarthout, Thandie S. Mwalukomo, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. e189-e198
Open Access | Times Cited: 5

RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding
Elena Mitsi, Elissavet Nikolaou, André Fernando Nascimento Gonçalves, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 9, pp. 1608-1620.e4
Closed Access | Times Cited: 3

A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection Challenge
Helen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 8, pp. 868-878
Open Access | Times Cited: 8

Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3)
Phoebe Hazenberg, Ryan Robinson, Madlen Farrar, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e075948-e075948
Open Access | Times Cited: 1

Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment
Charles Reynard, James Campling, Adam Gordon, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1052-1067
Open Access | Times Cited: 1

A Randomised Controlled Trial of Nasal Immunisation with Live Virulence AttenuatedStreptococcus pneumoniaeStrains using Human Infection Challenge
Helen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Experimental Human Pneumococcal Carriage using Streptococcus pneumoniae serotype 3 in Malawi: a dose ranging and reproducibility human infection study
Tarsizio Chikaonda, Anthony Emeritus Chirwa, Gareth Lipunga, et al.
Wellcome Open Research (2024) Vol. 9, pp. 467-467
Open Access

Comprehensive review of safety in Experimental Human Pneumococcal Challenge
Ryan Robinson, Christopher Myerscough, Nengjie He, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0284399-e0284399
Open Access | Times Cited: 1

Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022
Megan V. C. Barnes, Anika Mandla, Emma Smith, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 1

An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies
Birgitta Henriques‐Normark, Ana Rita Narciso
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 11, pp. 1312-1314
Open Access

Page 1

Scroll to top